Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 832 record(s)

Req # A-2023-000761

The following contracts: Reference number: C-2021-2022-Q4-00796 HC Procurement Identification: H105125451. Reference number: C-2021-2022-Q4-00798 HC Procurement Identification: H105125521. Reference number: C-2022-2023-Q1-00533 HC Procurement Identification: H105124231.

Organization: Health Canada

39 page(s)
November 2023

Req # A-2023-000806

The total amounts expended for advertising related to COVID-19 awareness from June 1, 2020 to December 31, 2022. The list of advertising expenditures incurred by the Department during the 2020/21, 2021/22 and 2022/23 fiscal years on a monthly basis for the same reason during the same period.

Organization: Health Canada

7 page(s)
November 2023

Req # A-2023-000826

Health Canada currently has two generic submissions under review for the drug Eplerenone. The following information for these submissions: Date of application Manufacturer or Company Class, Product type Submission type Canadian reference product Dosage form Route(s) of administration Medical ingredient(s) Strength.

Organization: Health Canada

68 page(s)
November 2023

Req # A-2023-000880

The statistics of people that use and die due to opioids between 2022 and 2023.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000883

The briefing book prepared by the Department for the incoming new Minister of Health, Mark Holland following the recent cabinet shuffle.

Organization: Health Canada

221 page(s)
November 2023

Req # A-2023-000889

Evidence that proves that long-term exposure to frequencies above 3 GHz, which would include the frequencies for 5G technologies, is safe for children, pregnant women, and electro hypersensitive individuals.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000934

Data on Safety and Effectiveness reviews for drugs used by humans. Reviews conducted between January 1, 2013 to October 9, 2023.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000940

All available information concerning reports, studies or analyses since 2017 in relation to male contraception.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000942

Any medical device establishment license held by SureScreen Corporation from 2012 to 2022 inclusive.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2023-000943

A list of closed legal cases that involved a drug or medical device where Health Canada was named as a defendant dating back to 2000.

Organization: Health Canada

3 page(s)
November 2023
Date modified: